{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:21:07Z","timestamp":1790198467436,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tem.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T05:11:03Z","timestamp":1730956263000},"page":"389-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is cardiovascular disease in PCOS driven by MASLD?"],"prefix":"10.1016","volume":"36","author":[{"given":"Huadong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pomme I.H.G.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-3331","authenticated-orcid":false,"given":"Martijn C.G.J.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2024.10.005_bb0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"De Groot","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tem.2024.10.005_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/cen.14593","article-title":"Causal relationship between polycystic ovary syndrome and coronary artery disease: a Mendelian randomisation study","volume":"96","author":"Simons","year":"2022","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2024.10.005_bb0015","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2024.10.005_bb0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2023.02.006","article-title":"Adolescent PCOS: a postpubertal central obesity syndrome","volume":"29","author":"Ibanez","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tem.2024.10.005_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12916-023-02775-0","article-title":"The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.tem.2024.10.005_bb0030","first-page":"3979","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone\u2013binding globulin gene","volume":"117","author":"Selva","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2024.10.005_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cen.14459","article-title":"Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans","volume":"95","author":"Simons","year":"2021","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.tem.2024.10.005_bb0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.32534","article-title":"Relationship between NAFLD and coronary artery disease: a Mendelian randomization study","volume":"77","author":"Ren","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.tem.2024.10.005_bb0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ecl.2023.01.002","article-title":"Cardiovascular implications of metabolic dysfunction-associated fatty liver disease","volume":"52","author":"Ren","year":"2023","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.tem.2024.10.005_bb0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/ejendo\/lvae006","article-title":"Fructose intake from sugar-sweetened beverages is associated with a greater risk of hyperandrogenism in women: UK Biobank cohort study","volume":"190","author":"Chen","year":"2024","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2024.10.005_bb0055","first-page":"1917","article-title":"Comment on Lee et al. Relation of change or substitution of low-and no-calorie sweetened beverages with cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies","volume":"45","author":"Buziau","year":"2023","journal-title":"Diabetes Care 2022"},{"key":"10.1016\/j.tem.2024.10.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013927","article-title":"Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.tem.2024.10.005_bb0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2024.10.005_bb0070","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled Phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2024.10.005_bb0075","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327602400273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327602400273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T14:57:20Z","timestamp":1746457040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104327602400273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S104327602400273X"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2024.10.005","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is cardiovascular disease in PCOS driven by MASLD?","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}